← Leaderboards
Ivan M Robbins
Vanderbilt University
$2,964,589
Attributed
$2,964,589
Total exposure
7
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $532.7K · FY2005–16$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$2,964,589 · 7
By mechanism
P01$2,285,872 · 1
K23$624,240 · 1
M01$44,477 · 4
R13$10,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- James E Loyd$19,105,238
- Eric Douglas Austin$6,099,747
- Rizwan Hamid$10,654,735
- David M Kerins$6,093
- Nancy Joan Brown$32,445,188
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectHuman Therapy EvaluationPulmonary HypertensionCardiovascular Disorder ChemotherapyProstacyclinsPharmacokineticsThromboxanesProstaglandinsPulmonary CirculationClinical TrialsDrug Administration RoutesRenin Angiotensin SystemCongenital Heart DisorderHemodynamicsExerciseEnzyme InhibitorsFundingLeukocyte Activation /TransformationDisease /Disorder EtiologyCooperative StudyCollaborationsAngiographyAce Inhibitors
Grant awards (25)
Clinical and Statistical Support Core/Loyd$423,064
P01 · FY2016 · HL · contact PI
Clinical and Statistical Support Core/Loyd$427,863
P01 · FY2015 · HL · contact PI
Clinical and Statistical Support Core/Loyd$104,864
P01 · FY2015 · HL · contact PI
Clinical and Statistical Support Core/Loyd$423,982
P01 · FY2014 · HL · contact PI
Clinical and Statistical Support Core/Loyd$432,045
P01 · FY2013 · HL · contact PI
Clinical and Statistical Support Core/Loyd$474,054
P01 · FY2012 · HL · contact PI
IXth International Pulmonary Hypertension Conference: Scientific Sessions$10,000
R13 · FY2010 · HL · contact PI
A PILOT STUDY COMPARING ANTI-PLATELET THERAPIES AND PLACEBO IN PULMONARY ARTE$460
M01 · FY2005 · RR
Mentored Patient-Oriented Research Career Development Aw$124,848
K23 · FY2004 · RR
A pilot study comparing anti-platelet therapies and placebo in pulmonary arte...$22,559
M01 · FY2004 · RR
Evaluation of Circulating Lipid and Protein Mediators in Patients$21,458
M01 · FY2004 · RR
Mentored Patient-Oriented Research Career Development Aw$124,848
K23 · FY2003 · RR
Mentored Patient-Oriented Research Career Development Aw$124,848
K23 · FY2002 · RR
CYCLOOXYGENASE 2 INHIB ON EICOSANOID IN PULMONARY HYPERT$0
M01 · FY2002 · RR
CHRONIC SUBCUTANEOUS UT 15/PATIENTS W/ PULMONARY HYPERTE$0
M01 · FY2002 · RR
Mentored Patient-Oriented Research Career Development Aw$124,848
K23 · FY2001 · RR
CYCLOOXYGENASE 2 INHIB ON EICOSANOID IN PULMONARY HYPERT$0
M01 · FY2001 · RR
CYCLOOXYGENASE 2 INHIB ON EICOSANOID IN PULMONARY HYPERT$0
M01 · FY2001 · RR
CYCLOOXYGENASE 2 INHIB ON EICOSANOID IN PULMONARY HYPERT$0
M01 · FY2001 · RR
CHRONIC SUBCUTANEOUS UT 15/PATIENTS W/ PULMONARY HYPERTE$0
M01 · FY2001 · RR
CHRONIC SUBCUTANEOUS UT 15/PATIENTS W/ PULMONARY HYPERTE$0
M01 · FY2001 · RR
CHRONIC SUBCUTANEOUS UT 15/PATIENTS W/ PULMONARY HYPERTE$0
M01 · FY2001 · RR
Mentored Patient-Oriented Research Career Development Aw$124,848
K23 · FY2000 · RR
CYCLOOXYGENASE 2 INHIB ON EICOSANOID IN PULMONARY HYPERT$0
M01 · FY2000 · RR
CHRONIC SUBCUTANEOUS UT 15/PATIENTS W/ PULMONARY HYPERTE$0
M01 · FY2000 · RR